Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 6;22(16):8490.
doi: 10.3390/ijms22168490.

NGS in Hereditary Ataxia: When Rare Becomes Frequent

Affiliations

NGS in Hereditary Ataxia: When Rare Becomes Frequent

Daniele Galatolo et al. Int J Mol Sci. .

Abstract

The term hereditary ataxia (HA) refers to a heterogeneous group of neurological disorders with multiple genetic etiologies and a wide spectrum of ataxia-dominated phenotypes. Massive gene analysis in next-generation sequencing has entered the HA scenario, broadening our genetic and clinical knowledge of these conditions. In this study, we employed a targeted resequencing panel (TRP) in a large and highly heterogeneous cohort of 377 patients with a clinical diagnosis of HA, but no molecular diagnosis on routine genetic tests. We obtained a positive result (genetic diagnosis) in 33.2% of the patients, a rate significantly higher than those reported in similar studies employing TRP (average 19.4%), and in line with those performed using exome sequencing (ES, average 34.6%). Moreover, 15.6% of the patients had an uncertain molecular diagnosis. STUB1, PRKCG, and SPG7 were the most common causative genes. A comparison with published literature data showed that our panel would have identified 97% of the positive cases reported in previous TRP-based studies and 92% of those diagnosed by ES. Proper use of multigene panels, when combined with detailed phenotypic data, seems to be even more efficient than ES in clinical practice.

Keywords: Genesis; HA; TRP; cohort; diagnostic yield; exome sequencing; mutation; next-generation sequencing; targeted resequencing panel; variant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Features of the initial cohort, including the possibility of performing segregation studies (violet).
Figure 2
Figure 2
(A) Overall diagnostic yield achieved in this study compared with average results of TRP and ES approaches as described in the literature; (B) Diagnostic yield presented by specific features.
Figure 3
Figure 3
Comparison of molecular findings between this study (black) and literature (green) in terms of (A) mutation types and patterns of inheritance, (B) most common disease-causing genes, and (C) pathways involved.

Similar articles

Cited by

References

    1. Jayadev S., Bird T.D. Hereditary ataxias: Overview. Genet. Med. 2013;15:673–683. doi: 10.1038/gim.2013.28. - DOI - PubMed
    1. Synofzik M., Schüle R. Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways. Mov. Disord. 2017;32:332–345. doi: 10.1002/mds.26944. - DOI - PMC - PubMed
    1. Ruano L., Silva M.C., Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: A systematic review of prevalence studies. Neuroepidemiology. 2014;42:174–183. doi: 10.1159/000358801. - DOI - PubMed
    1. Klockgether T., Mariotti C., Paulson H.L. Spinocerebellar ataxia. Nat. Rev. Dis. Prim. 2019;5:24. doi: 10.1038/s41572-019-0074-3. - DOI - PubMed
    1. Galatolo D., Tessa A., Filla A., Santorelli F.M. Clinical application of next generation sequencing in hereditary spinocerebellar ataxia: Increasing the diagnostic yield and broadening the ataxia-spasticity spectrum. A retrospective analysis. Neurogenetics. 2018;19:1–8. doi: 10.1007/s10048-017-0532-6. - DOI - PubMed

LinkOut - more resources